1458 related articles for article (PubMed ID: 22103635)
21. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Cady RK; Diamond ML; Diamond MP; Ballard JE; Lener ME; Dorner DP; Derosier FJ; McDonald SA; White J; Runken MC
Headache; 2011 May; 51(5):664-73. PubMed ID: 21521204
[TBL] [Abstract][Full Text] [Related]
22. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
23. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
24. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE
JAMA; 2007 Apr; 297(13):1443-54. PubMed ID: 17405970
[TBL] [Abstract][Full Text] [Related]
25. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
26. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults.
Winner P; Adelman J; Aurora S; Lener ME; Ames M
Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114
[TBL] [Abstract][Full Text] [Related]
28. A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study.
Mehlisch DR; Aspley S; Daniels SE; Southerden KA; Christensen KS
Clin Ther; 2010 Jun; 32(6):1033-49. PubMed ID: 20637958
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
31. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
[TBL] [Abstract][Full Text] [Related]
32. A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
Goldstein J; Smith TR; Pugach N; Griesser J; Sebree T; Pierce M
Headache; 2012 Oct; 52(9):1402-10. PubMed ID: 22694484
[TBL] [Abstract][Full Text] [Related]
33. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
34. Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.
Landy SH; Cady RK; Nelsen A; White J; Runken MC
Headache; 2014 Apr; 54(4):640-54. PubMed ID: 24102322
[TBL] [Abstract][Full Text] [Related]
35. Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
Silberstein SD; Freitag FG; Rozen TD; Kudrow DB; Hewitt DJ; Jordan DM; Fisher AC; Rosenthal NR;
Headache; 2005; 45(10):1317-27. PubMed ID: 16324164
[TBL] [Abstract][Full Text] [Related]
36. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.
McDonald SA; Hershey AD; Pearlman E; Lewis D; Winner PK; Rothner D; Linder SL; Runken MC; Richard NE; Derosier FJ
Headache; 2011 Oct; 51(9):1374-87. PubMed ID: 21797863
[TBL] [Abstract][Full Text] [Related]
37. Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study.
Silberstein S; McDonald SA; Goldstein J; Aurora S; Lener SE; White J; Runken MC; Saiers J; Derosier F; Lipton RB
Cephalalgia; 2014 Apr; 34(4):268-79. PubMed ID: 24108307
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function.
Edwards KR; Rosenthal BL; Farmer KU; Cady RK; Browning R
Headache; 2013 Apr; 53(4):656-64. PubMed ID: 23406052
[TBL] [Abstract][Full Text] [Related]
39. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
40. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
